%0 Journal Article
%T Right ventricular phenotyping in incident patients with idiopathic pulmonary arterial hypertension.
%A Ghio S
%A Badagliacca R
%A D'Alto M
%A Scelsi L
%A Argiento P
%A Brunetti ND
%A Casu G
%A Cedrone N
%A Confalonieri M
%A Corda M
%A Correale M
%A D'Agostino C
%A De Tommasi E
%A Filomena D
%A Galgano G
%A Greco A
%A Grimaldi M
%A Lombardi C
%A Madonna R
%A Manzi G
%A Mercurio V
%A Mihai A
%A Mulè M
%A Paciocco G
%A Papa S
%A Recchioni T
%A Romaniello A
%A Romeo E
%A Stolfo D
%A Vitulo P
%A Benza RL
%A Vizza CD
%A
%J J Heart Lung Transplant
%V 0
%N 0
%D 2024 Jun 26
%M 38942159
%F 13.569
%R 10.1016/j.healun.2024.06.003
%X BACKGROUND: Right ventricular (RV) imaging has not a definite role in risk stratification of pulmonary arterial hypertension (PAH) patients. We tested the hypothesis that echocardiography-derived phenotypes, depicting different degrees of RV remodeling and dysfunction, may provide additional prognostic information to current risk stratification tools.
METHODS: Consecutive incident PAH patients aged ≥18 years, diagnosed between January 2005 and December 2021, underwent clinical assessment, right heart catheterization, standard echocardiography. Simple echocardiographic variables were combined in order to define a priori four phenotypes representing different degrees of RV dilatation and RV-pulmonary arterial (PA) coupling: Phenotype 1 with mildy dilated right ventricle and preserved RV-PA coupling (n = 152 patients); phenotype 2 with mildly dilated right ventricle and poor RV-PA coupling (n = 143 patients); phenotype 3 with severely dilated right ventricle and preserved RV-PA coupling (n = 201 patients); phenotype 4 with severely dilated right ventricle and poor RV-PA coupling, with or without severe tricuspid regurgitation (n = 519 patients). Risk stratification was based on the European Society of Cardiology/European Respiratory Society (ESC/ERS) 3-strata model and Registry to Evaluate Early and Long-Term PAH disease Management (REVEAL) 2.0 score.
RESULTS: These phenotypes were present in all risk groups. Notably, regardless of the ESC/ERS risk stratum assigned to the patient, phenotype 4 was associated with a 2-fold increase of the odds of death (HR 2.1, 95% CI 1.6-2.8, p < 0.001), while phenotype 1 was associated with a 71% reduction in the odds of dying (HR 0.29, 95% CI 0.18-0.47, p < 0.001).
CONCLUSIONS: Echocardiography-derived phenotypes describing RV remodeling and dysfunction may provide prognostic information which is independent of and additional to the clinically defined risk in incident PAH patients.